Recent study revealed that the increased expression of phosphofructokinase platelet (PFKP) is tightly connected with metabolic activities to reduce the chemotherapy sensitivity in leukemia initiating cells (LICs) [51]. This evidence concerns the gene PFKP and leukemia.